← Browse by Condition
Medical Condition

moderately to severely active crohns disease

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 3
NCT06819891 Phase 3
Recruiting

A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

Enrollment
425 pts
Location
United States, Argen...
Sponsor
Hoffmann-La Roche
View Trial →